Thanks for the response, but FWIW I was making a half flippant, half serious comment that he seems to believe in doing everything up front instead of in a way that leverages growth. (It may not hurt him, personally, too much, because he’ll always get new grants - but if he has to significantly raise again it’s going to get ugly. Not clear anyone who bought up in the 30’s can ever get well even with a $1.5B drug.)
Market Data 
Markets 
AI
